1. Home
  2. XNET vs THRD Comparison

XNET vs THRD Comparison

Compare XNET & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNET
  • THRD
  • Stock Information
  • Founded
  • XNET 2003
  • THRD 2019
  • Country
  • XNET China
  • THRD United States
  • Employees
  • XNET 1216
  • THRD N/A
  • Industry
  • XNET Computer Software: Prepackaged Software
  • THRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • XNET Technology
  • THRD Health Care
  • Exchange
  • XNET Nasdaq
  • THRD Nasdaq
  • Market Cap
  • XNET 373.0M
  • THRD 232.4M
  • IPO Year
  • XNET 2014
  • THRD 2022
  • Fundamental
  • Price
  • XNET $5.53
  • THRD $5.23
  • Analyst Decision
  • XNET
  • THRD Hold
  • Analyst Count
  • XNET 0
  • THRD 3
  • Target Price
  • XNET N/A
  • THRD $5.00
  • AVG Volume (30 Days)
  • XNET 652.6K
  • THRD 303.3K
  • Earning Date
  • XNET 05-15-2025
  • THRD 05-08-2025
  • Dividend Yield
  • XNET N/A
  • THRD N/A
  • EPS Growth
  • XNET N/A
  • THRD N/A
  • EPS
  • XNET N/A
  • THRD N/A
  • Revenue
  • XNET $331,614,000.00
  • THRD N/A
  • Revenue This Year
  • XNET N/A
  • THRD N/A
  • Revenue Next Year
  • XNET N/A
  • THRD N/A
  • P/E Ratio
  • XNET N/A
  • THRD N/A
  • Revenue Growth
  • XNET N/A
  • THRD N/A
  • 52 Week Low
  • XNET $1.46
  • THRD $3.18
  • 52 Week High
  • XNET $7.19
  • THRD $16.02
  • Technical
  • Relative Strength Index (RSI)
  • XNET 56.11
  • THRD 74.22
  • Support Level
  • XNET $5.29
  • THRD $5.16
  • Resistance Level
  • XNET $7.19
  • THRD $5.22
  • Average True Range (ATR)
  • XNET 0.50
  • THRD 0.04
  • MACD
  • XNET 0.04
  • THRD -0.04
  • Stochastic Oscillator
  • XNET 40.52
  • THRD 100.00

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Share on Social Networks: